Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 7/20 | 0.73 |
| ▸ | MAPT | P10636 | 6/20 | 0.73 |
| ▸ | KMT2A | Q03164 | 6/20 | 0.73 |
| ▸ | LMNA | P02545 | 2/20 | 0.71 |
| ▸ | MPI | P34949 | 1/20 | 0.71 |
| ▸ | THRB | P10828 | 3/20 | 0.64 |
| ▸ | THRA | P10827 | 2/20 | 0.64 |
| ▸ | TP53 | P04637 | 1/20 | 0.62 |
| ▸ | ALDH3A1 | P30838 | 1/20 | 0.62 |
| ▸ | HTT | P42858 | 1/20 | 0.62 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.62 |
| ▸ | GAA | P10253 | 1/20 | 0.58 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.58 |
| ▸ | EGFR | P00533 | 1/20 | 0.57 |
| ▸ | MEN1 | O00255 | 1/20 | 0.57 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL7932182 | 0.98 | ALDH1A1 (0.74) | ALDH1A1MAPTKMT2ALMNAMPI | |
| SCHEMBL9512833 | 0.92 | ALDH1A1 (0.84) | ALDH1A1MAPTKMT2ALMNAMPI | |
| SCHEMBL1140551 | 0.85 | ALDH1A1 (0.68) | ALDH1A1MAPTKMT2ALMNATHRB | |
| SCHEMBL7255774 | 0.84 | ALDH1A1 (1.00) | ALDH1A1MAPTKMT2ALMNAMPI | |
| SCHEMBL12123771 | 0.84 | ALDH1A1 (0.73) | ALDH1A1MAPTKMT2ALMNAMPI | |
| SCHEMBL12123826 | 0.84 | ALDH1A1 (0.73) | ALDH1A1MAPTKMT2ALMNAMPI | |
| SCHEMBL12123789 | 0.84 | ALDH1A1 (0.97) | ALDH1A1MAPTKMT2ALMNAMPI | |
| SCHEMBL12947818 | 0.84 | KMT2A (0.69) | ALDH1A1MAPTKMT2ALMNAHTT | |
| SCHEMBL321369 | 0.84 | ALDH1A1 (1.00) | ALDH1A1MAPTKMT2ALMNAMPI | |
| SCHEMBL12123614 | 0.84 | ALDH1A1 (0.71) | ALDH1A1MAPTKMT2ALMNATHRB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-110596259-B | Method for identifying storage time of pine pollen based on metabonomics analysis | 烟台新时代健康产业有限公司 | 2022-03-01 | — | — | CN | disclosed |
| CN-110596258-B | Method for identifying sterilization mode of pine pollen based on metabonomics analysis | 烟台新时代健康产业有限公司 | 2022-03-01 | — | — | CN | disclosed |
| CN-110596259-A | Method for identifying storage time of pine pollen based on metabonomics analysis | 烟台新时代健康产业有限公司 | 2019-12-20 | — | — | CN | disclosed |
| CN-110596258-A | Method for identifying sterilization mode of pine pollen based on metabonomics analysis | 烟台新时代健康产业有限公司 | 2019-12-20 | — | — | CN | disclosed |
| US-20150290200-A1 | INTRACELLULAR KINASE INHIBITORS | PHARMACYCLICS INC (US) | 2015-10-15 | — | — | US | disclosed |
| US-20150290200-A1 | INTRACELLULAR KINASE INHIBITORS | PHARMACYCLICS INC (US) | 2015-10-15 | — | — | US | disclosed |
| EP-2865381-A1 | ITK inhibitors for treating blood cell malignancies | Pharmacyclics, Inc. (US) | 2015-04-29 | — | — | EP | disclosed |
| US-20140080833-A1 | INTRACELLULAR KINASE INHIBITORS | MANNKIND CORPORATION (US) | 2014-03-20 | — | — | US | disclosed |
| US-20140080833-A1 | INTRACELLULAR KINASE INHIBITORS | MANNKIND CORPORATION (US) | 2014-03-20 | — | — | US | disclosed |
| US-20110281850-A1 | INTRACELLULAR KINASE INHIBITORS | MANNKIND CORPORATION (US) | 2011-11-17 | — | — | US | disclosed |
| US-20110281850-A1 | INTRACELLULAR KINASE INHIBITORS | MANNKIND CORPORATION (US) | 2011-11-17 | — | — | US | disclosed |
| US-20070293499-A1 | Intracellular Kinase Inhibitors | MANNKIND CORPORATION (US) | 2007-12-20 | — | — | US | disclosed |
| US-20070293499-A1 | Intracellular Kinase Inhibitors | MANNKIND CORPORATION (US) | 2007-12-20 | — | — | US | disclosed |
| WO-2007136790-A2 | INTRACELLULAR KINASE INHIBITORS | MANNKIND CORPORATION (US) | 2007-11-29 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070293499-A1 | Intracellular Kinase Inhibitors | PI4KB, BTK, LTK | ALDH1A1 4370/4885MAPT 3284/4885KMT2A 1458/4885 |
| US-20150290200-A1 | INTRACELLULAR KINASE INHIBITORS | PI4KB, BTK, LTK | ALDH1A1 4370/4885MAPT 3284/4885KMT2A 1458/4885 |
| US-20110281850-A1 | INTRACELLULAR KINASE INHIBITORS | PI4KB, BTK, LTK | ALDH1A1 4370/4885MAPT 3284/4885KMT2A 1458/4885 |
| US-20140080833-A1 | INTRACELLULAR KINASE INHIBITORS | PI4KB, BTK, LTK | ALDH1A1 4370/4885MAPT 3284/4885KMT2A 1458/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.